Antibacterial Drugs Market By Drug Type (Aminoglycosides, B-Lactams, Tetracyclines, Sulfonamides, Quinolones, Macrolides, Phenicols, Miscellaneous) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

This report on global antibacterial drugs market studies various drug classes used for treatment of bacterial infections along with pipeline analysis of upcoming potential drugs.  Bacterial infection, irrespective of its etiology is an important concern in patients with cirrhosis since it is associated with increased morbidity and mortality. According to World Health Organization (WHO), cirrhotic patients from developed countries indicate urinary tract infections (12 – 29%) to be the most frequent cause for bacterial sepsis followed by spontaneous bacterial peritonitis (15 – 23%), respiratory tract infection (6 – 10%) and bacteremia (4-9%).

For the purpose of this study, the various drug classes studied include aminoglycosides, beta-lactams, tetracyclines, sulfonamides, quinolones, macrolides, phenicols and miscellaneous antibacterials. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective CAGRs for the period 2016 to 2022, considering 2015 as the base year.

The pipeline analysis for antibacterial drugs market comprises projected market sales of Phase III drugs estimated till 2022. The phase III drugs included in the pipeline analysis are solithromycin (Cempra, Inc.), VivaGel/ SPL7013 (Starpharma Holdings Limited), surotomycin (Merck & Co.), MK-3415A (Merck & Co.) and others. The report also covers qualitative information associated with the drugs under phase II and I of the clinical trials.

The geographic segmentation of the global antibacterial drugs market is performed for the regions North America, Europe, Asia Pacific and Rest of the World markets. The regions are also further sub-segmented on the basis of major countries. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective CAGRs for the period 2016 to 2022, considering 2015 as the base year.

Antibacterial Drugs Market

For the purpose of this study, the global antibacterial drugs market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East Africa

Antibacterial Drugs Market

In base year 2015, it was observed that Asia Pacific dominated the overall market and is also projected to witness the fastest growth during the forecast period 2016 - 2022. The key factors assisting the growth of  Asia Pacific antibacterial drugs market are it accounts for the largest infected population in the world with a variety of bacterial infections such as pneumonia, tuberculosis and tetanus, presence of large number of manufacturers of active pharmaceutical ingredient and generic drugs, high disposable income, rising geriatric population, and emerging healthcare infrastructure. North America, followed by Europe, is the second largest antibacterial drugs market globally in terms of revenue. North America and Europe are anticipated to witness slow growth over the forecast period due to stringent regulatory policies, abridged product lifecycle, and generic penetration.

Choose License Type
Published Date:  Jun 2016
Category:  Medical Devices
Report ID:   57891
Report Format:   PDF
Pages:   120
Rating:    4.5 (65)
Connect With Us
+1-408-641-3282
24/7 Research Support